P. Cheng

C. Jen, N. Chow, K. Young, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

C. Tsao, W. Tsai, Ting Chang, 2017, Cellular microbiology.

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

Mei-Hsuan Lee, J. Kao, Chun-Jen Liu, 2021, Infectious Diseases and Therapy.

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan.

Chun-Jen Liu, Ming‐Lung Yu, P. Cheng, 2020, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection

W. Tsai, K. Young, Hung-Yu Sun, 2017, Gut.

Real-world effectiveness and safety of sofosbuvir plus daclatasvir with or without ribavirin for genotype 2 chronic hepatitis C in Taiwan.

P. Cheng, Yen-Cheng Chiu, Hung-Chih Chiu, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Real‐world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan

Jyh-Jou Chen, P. Cheng, Yen-Cheng Chiu, 2020, Journal of gastroenterology and hepatology.

Aeromonas spontaneous bacterial peritonitis: a highly fatal infectious disease in patients with advanced liver cirrhosis.

B. Sheu, W. Ko, Chiung‐Yu Chen, 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

Lin28B Is an Oncofetal Circulating Cancer Stem Cell-Like Marker Associated with Recurrence of Hepatocellular Carcinoma

Chung-Liang Ho, C. Yen, N. Chow, 2013, PloS one.

Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study

E. Ravussin, S. Klein, C. Ukomadu, 2022, Nature Network Boston.

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

M. Lai, D. Shieh, Shainn-Wei Wang, 2012, Gut.

Range of Normal Liver stiffness and Predictors of Suspected Advanced Fibrosis in Apparently Healthy Individuals: A Pooled Analysis of 16,082 Participants

M. Kumar, V. Wong, K. Chayama, 2018 .

CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.

K. Young, P. Cheng, Li-Ling Chang, 2007, Antiviral research.

Surgical Resection is An Effective Therapy for Single Large Hepatocellular Carcinom

C. Hung, P. Cheng, P. Hsieh, 2021 .

Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents.

Pei-Jer Chen, T. Tseng, J. Kao, 2021, Journal of the Formosan Medical Association = Taiwan yi zhi.

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals

J. Kao, Chia-Chi Wang, Han‐Chieh Lin, 2022, Viruses.

Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss

Ting Chang, Wen-Chun Liu, I. Wu, 2021, Microorganisms.

High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy.

Ding‐Shinn Chen, T. Tseng, J. Kao, 2020, The Journal of infectious diseases.

The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan

T. Tseng, J. Kao, Chun-Jen Liu, 2022, Journal of gastroenterology and hepatology.

The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program: Erratum

P. Cheng, Yen-Cheng Chiu, Hung-Chih Chiu, 2016, Medicine.

Limited drug-drug interaction of elbasvir/grazoprevir for chronic hepatitis C.

Chun-Jen Liu, P. Cheng, Ching-chu Lo, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2019, Journal of gastroenterology and hepatology.

The needs of surveillance of metabolic associated fatty liver disease in Taiwan

P. Cheng, 2021, Advances in Digestive Medicine.

Low dose erythropoietin‐beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa‐2b

A. Chou, Ting Chang, I. Wu, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of hepatology.

Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients

Ting Chang, P. Cheng, 2008, Expert review of anti-infective therapy.

Persistent augmentation of central arterial stiffness following viral clearance by direct‐acting antivirals in chronic hepatitis C

P. Cheng, Yen-Cheng Chiu, W. Tsai, 2020, Journal of viral hepatitis.

Interspousal transmission of hepatitis C virus: application of comparing the variability of HVR1 nucleotide region.

Ting Chang, K. Young, P. Cheng, 2004, Hepato-gastroenterology.

HCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV

C. Yen, B. Chang, Ting Chang, 2017 .

Prediction of early hepatocellular carcinoma recurrence using germinal center kinase-like kinase

T. Tan, Ting Chang, H. Tsai, 2016, Oncotarget.

HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis B.

Ting Chang, H. Tsai, I. Wu, 2014, Annals of hepatology.

Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients.

Ting Chang, Wen-Chun Liu, I. Wu, 2020, Antiviral research.

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy

Chiung‐Yu Chen, Ting Chang, Wen-Chun Liu, 2018, World journal of gastroenterology.

Limitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine.

C. Jen, K. Young, P. Cheng, 2001, Journal of virological methods.

TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes.

Chien-Jen Chen, J. Kao, Chih-Cheng Hsu, 2023, Journal of the Formosan Medical Association = Taiwan yi zhi.

Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents

Ting Chang, H. Tsai, K. Young, 2011, Journal of medical virology.

Hepatotoxicity Associated with Acarbose Therapy

Ta‐Jen Wu, P. Cheng, S. Hsiao, 2006, The Annals of pharmacotherapy.

HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during adefovir dipivoxil therapy.

A. Chou, Chin-Kuo Chang, Ting Chang, 2009, Hepato-gastroenterology.

Immune Response to Hepatitis B Vaccine of 3 f " , td Subjects with Isolated Antibody to Hepatitis B 4 CD Core Antigen ih

C. Jen, Ting Chang, K. Young, 2005 .

Racial differences in responses to interferon‐β‐1a in chronic hepatitis C unresponsive to interferon‐α: a better response in Chinese patients

P. Marcellin, B. Bacon, Ting Chang, 2004, Journal of viral hepatitis.

Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study.

J. Kao, Jyh-Jou Chen, Yi‐Hsiang Huang, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Clinical analysis of choledochoduodenal fistula with cholelithiasis in Taiwan: assessment by endoscopic retrograde cholangiopancreatography.

B. Sheu, P. Cheng, J. Shin, 1996, The American journal of gastroenterology.

Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma

Chung-Liang Ho, C. Yen, N. Chow, 2018, World journal of gastroenterology.

Systematic review: chronic viral hepatitis and metabolic derangement

J. Kao, Chia-Chi Wang, P. Cheng, 2019, Alimentary pharmacology & therapeutics.

Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer

P. Liao, Y. Tyan, W. Lai, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Existence of Hepatitis C Virus in Culex quinquefasciatus after Ingestion of Infected Blood: Experimental Approach to Evaluating Transmission by Mosquitoes

Hua-Lin Wu, Ting Chang, K. Young, 2001, Journal of Clinical Microbiology.

Splenic infarction after histoacryl injection for bleeding gastric varices.

B. Sheu, Chiung‐Yu Chen, Xi-Zhang Lin, 1998, Gastrointestinal endoscopy.

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

M. Kumar, V. Wong, V. de Lédinghen, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis

Chiung‐Yu Chen, Ting Chang, I. Wu, 2021, Cancer Immunology, Immunotherapy.

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan

J. Kao, Chun-Jen Liu, S. Yeh, 2021, Viruses.

Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients

P. Cheng, Yen-Cheng Chiu, L. Tsai, 2019, Scientific Reports.

Association of serum IgG N-glycome and transforming growth factor-β1 with hepatitis B virus e antigen seroconversion during entecavir therapy.

R. Chien, Ting Chang, Shu-hui Chen, 2014, Antiviral research.

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions.

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG

R. Chien, Ting Chang, H. Tsai, 2017, Scientific Reports.

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Hepatology International.

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, The American journal of gastroenterology.

Seroprevalence of hepatitis E virus infection among institutionalized psychiatric patients in Taiwan.

Ting Chang, K. Young, I. Wu, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy.

R. Chien, Ting Chang, H. Tsai, 2015, The Journal of infectious diseases.

Molecular evidence for transmission of GB virus-C/Hepatitis G virus infection within family: close relationship between mother and child.

C. Jen, Hua-Lin Wu, Ting Chang, 2003, Hepato-gastroenterology.

Severe gangrene of the stomach and infarction of the liver and spleen after percutaneous ethanol injection for hepatocellular carcinoma: Report of a case

A. Chou, P. Cheng, H. Tsai, 2006 .

Clinical prognosis of surgical resection versus transarterial chemoembolization for single large hepatocellular carcinoma (≥5 cm): A propensity score matching analysis

C. Hung, P. Cheng, Kuang-Chun Hu, 2023, The Kaohsiung journal of medical sciences.

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients

Chun-Jen Liu, Chun‐Hsiang Wang, W. Su, 2015, PloS one.

Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study

Hsiu‐Chi Cheng, Chiung‐Yu Chen, Ting Chang, 2018, Liver Cancer.

Therapy with interferon‐α and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA‐ABC, CD86, and CD28 on peripheral blood mononuclear cells

Ting Chang, K. Young, Ya-Ling Wei, 2008, Journal of medical virology.

Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents.

K. Young, Hung-Yu Sun, P. Cheng, 2023, Journal of virus eradication.

Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C.

Jyh-Jou Chen, P. Cheng, Yen-Cheng Chiu, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan.

Ting Chang, I. Wu, P. Cheng, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection

H. Tsai, P. Cheng, Yen-Cheng Chiu, 2022, Viruses.

Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection

E. Asante-Appiah, R. Talwani, P. Perumalswami, 2019, Journal of gastroenterology and hepatology.

Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

R. Talwani, I. Sheen, J. George, 2018, Hepatology communications.

Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study

E. Asante-Appiah, R. Talwani, Fu-Sheng Wang, 2018, Journal of gastroenterology and hepatology.

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.

Yu‐Ju Chen, Hsin‐Yi Wu, P. Liao, 2015, Journal of proteome research.

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Scientific Reports.

Impact of sofosbuvir-based direct-acting antivirals on renal function in chronic hepatitis C patients with impaired renal function: a large cohort study from the nationwide HCV Registry Program (TACR).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.

J. Kao, Jyh-Jou Chen, Yi‐Hsiang Huang, 2019, The Journal of infectious diseases.

Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan

J. Kao, Jyh-Jou Chen, Yi‐Hsiang Huang, 2018, Alimentary pharmacology & therapeutics.

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, Open forum infectious diseases.

The characteristics of residents with unawareness of hepatitis C virus infection in community

P. Cheng, Yen-Cheng Chiu, Hung-Chih Chiu, 2018, PloS one.

Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community

P. Cheng, Yen-Cheng Chiu, Hung-Chih Chiu, 2018, PloS one.